The effects of aspirin and nonselective beta blockade on the acute prothrombotic response to psychosocial stress in apparently healthy subjects

Journal of Cardiovascular Pharmacology

Volumn 51, Issue 3, 2008, Pages 231-238

  Känel, Roland Von ^a,b   Kudielka, Brigitte M ^c   Helfricht, Susanne ^a   Metzenthin, Petra ^d   Preckel, Daniel ^a   Haeberli, André ^a   Cung, Trinh ^a   Fischer, Joachim E ^e  

^a UNIVERSITY OF BERN   (Switzerland)

^b BERN UNIVERSITY HOSPITAL   (Switzerland)

^c UNIVERSITY OF TRIER   (Germany)

^d BERN UNIVERSITY OF APPLIED SCIENCES   (Switzerland)

^e UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Cardiovascular disease; Drugs; Hemostasis; Psychological stress

Indexed keywords

ACETYLSALICYLIC ACID; BLOOD CLOTTING FACTOR 12A; BLOOD CLOTTING FACTOR 7; D DIMER; FIBRINOGEN; HYDROCORTISONE; PLACEBO; PROPRANOLOL; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; BLOOD PRESSURE; BLOOD SAMPLING; BODY MASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY THROMBOSIS; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; GROUPS BY AGE; HEMOSTASIS; HUMAN; HUMAN EXPERIMENT; MALE; MEAN ARTERIAL PRESSURE; MENTAL STRESS; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; SLEEP; SMOKING;

ACUTE DISEASE; ADRENERGIC BETA-ANTAGONISTS; ADULT; ASPIRIN; CORONARY THROMBOSIS; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FACTOR VII; FACTOR XII; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOGEN; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PROPRANOLOL; STRESS, PSYCHOLOGICAL; VON WILLEBRAND FACTOR;

EID: 41349096108     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/FJC.0b013e318161ea63     Document Type: Article

References (48)

1. Bhattacharyya MR, Steptoe A. Emotional triggers of acute coronary syndromes: strength of evidence, biological processes, and clinical implications. Prog Cardiovasc Dis. 2007;49:353-365.
2. Servoss SJ, Januzzi JL, Muller JE. Triggers of acute coronary syndromes. Prog Cardiovasc Dis. 2002;44:369-380.
3. Virmani R, Kolodgie FD, Burke AP, et al. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol. 2000;20:1262-1275.
4. Turpie AG, Antman EM. Low-molecular-weight heparins in the treatment of acute coronary syndromes. Arch Intern Med. 2001;161:1484-1490.
5. Heper G, Bayraktaroglu M. The importance of von Willebrand factor level and heart rate changes in acute coronary syndromes: a comparison with chronic ischemic conditions. Angiology. 2003;54:287-299.
6. Bayes-Genis A, Mateo J, Santalo M, et al. D-Dimer is an early diagnostic marker of coronary ischemia in patients with chest pain. Am Heart J. 2000;140:379-384.
7. Campo G, Valgimigli M, Ferraresi P, et al. Tissue factor and coagulation factor VII levels during acute myocardial infarction: association with genotype and adverse events. Arterioscler Thromb Vasc Biol. 2006;26:2800-2806.
8. Grundt H, Nilsen DW, Hetland O, et al. Activated factor 12 (FXIIa) predicts recurrent coronary events after an acute myocardial infarction. Am Heart J. 2004;147:260-266.
9. von Kanel R, Mills PJ, Fainman C, et al. Effects of psychological stress and psychiatric disorders on blood coagulation and fibrinolysis: a biobehavioral pathway to coronary artery disease? Psychosom Med. 2001;63:531-544.
10. Thrall G, Lane D, Carroll D, et al. Systematic reviewof the effects of acute psychological stress and physical activity on haemorheology, coagulation, fibrinolysis and platelet reactivity: Implications for the pathogenesis of acute coronary syndromes. Thromb Res. 2007;120:819-847.
11. Gidron Y, Gilutz H, Berger R, et al. Molecular and cellular interface between behavior and acute coronary syndromes. Cardiovasc Res. 2002;56:15-21.
12. Strike PC, Magid K, Whitehead DL, et al. Pathophysiological processes underlying emotional triggering of acute cardiac events. Proc Natl Acad Sci USA. 2006;103:4322-4327.
13. Collaborative overview of randomised trials of antiplatelet therapy-I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration. BMJ. 1994;308:81-106.
14. Everly MJ, Heaton PC, Cluxton RJ Jr. Beta-blocker underuse in secondary prevention of myocardial infarction. Ann Pharmacother. 2004;38:286-293.
15. von Kanel R, Dimsdale JE. Effects of sympathetic activation by adrenergic infusions on hemostasis in vivo. Eur J Haematol. 2000;65:357-369.
16. von Kanel R, Dimsdale JE, Adler KA, et al. Effects of non-specific beta-adrenergic stimulation and blockade on blood coagulation in hypertension. J Appl Physiol. 2003;94:1455-1459.
17. von Kanel R, Preckel D, Zgraggen L, et al. The effect of natural habituation on coagulation responses to acute mental stress and recovery in men. Thromb Haemost. 2004;92:1327-1335.
18. Jern C, Eriksson E, Tengborn L, et al. Changes of plasma coagulation and fibrinolysis in response to mental stress. Thromb Haemost. 1989;62:767-771.
19. von Kanel R, Dimsdale JE, Adler KA, et al. Effects of depressive symptoms and anxiety on hemostatic responses to acute mental stress and recovery in the elderly. Psychiatry Res. 2004;126:253-264.
20. Wirtz PH, Ehlert U, Emini L, et al. Acute procoagulant stress reactivity and recovery in apparently healthy men with systolic anddiastolic hypertension. J Psychosom Res. 2007;63:51-58.
21. Folsom AR. Hemostatic risk factors for atherothrombotic disease: an epidemiologic view. Thromb Haemost. 2001;86:366-373.
22. Kannel WB. Overview of hemostatic factors involved in atherosclerotic cardiovascular disease. Lipids. 2005;40:1215-1220.
23. Lee KW. Lip GY. Effects of lifestyle on hemostasis, fibrinolysis, and platelet reactivity: a systematic review. Arch Intern Med. 2003;163:2368-2392.
24. von Kanel R, Loredo JS, Ancoli-Israel S, et al. Association between polysomnographic measures of disrupted sleep and prothrombotic factors. Chest. 2007;131:733-739.
25. von Kanel R, Kudielka BM, Preckel D, et al. Delayed response and lack of habituation in plasma interleukin-6 to acute mental stress in men. Brain Behav Immun. 2006;20:40-48.
26. nd revised edition. Oxford: Academic Press, 2007.
27. Dickerson SS, Kemeny ME. Acute stressors and cortisol responses: a theoretical integration and synthesis of laboratory research. Psychol Bull. 2004;130:355-391.
28. Herren T, Stricker H, Haeberli A, et al. Fibrin formation and degradation in patients with arteriosclerotic disease. Circulation. 1994;90:2679-2686.
29. Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol. 1957;17:237-246.
30. Sukhu K, Martin PG, Cross L, et al. Evaluation of the von Willebrand factor antigen (vWF-Ag) assay using an immuno-turbidimetric method (STA Liatest vWF) automated on the MDA 180 coagulometer. Clin Lab Haematol. 2000;22:29-32.
31. Westermann J, Demir A, Herbst V. Determination of cortisol in saliva and serum by a luminescence-enhanced enzyme immunoassay. Clin Lab. 2004;50:11-24.
32. Babyak MA. What you see may not be what you get: a brief, nontechnical introduction to overfitting in regression-type models. Psychosom Med. 2004;66:411-421.
33. von Kanel R, Kudielka BM, Metzenthin P, et al. Aspirin, but not propranolol, attenuates the acute stress-induced increase in circulating levels of interleukin-6: A randomized, double-blind, placebo-controlled study. Brain Behav Immun. (in press).
34. Wall RT, Counts RB, Harker LA, et al. Binding and release of factor VIII/von Willebrand's factor by human endothelial cells. Br J Haematol. 1980;46:287-298.
35. Vischer UM, Wollheim CB. Epinephrine induces von Willebrand factor release from cultured endothelial cells: involvement of cyclic AMP-dependent signalling in exocytosis. Thromb Haemost. 1997;77:1182-1188.
36. Larsson PT, Wallen NH, Martinsson A, et al. Significance of platelet betaadrenoceptors for platelet responses in vivo and in vitro. Thromb Haemost. 1992;68:687-693.
37. Schommer NC, Hellhammer DH, Kirschbaum C. Dissociation between reactivity of the hypothalamus-pituitary-adrenal axis and the sympathetic-adrenal- medullary system to repeated psychosocial stress. Psychosom Med. 2003;65:450-460.
38. Paran E, Neumann L, Cristal N. Effects of mental and physical stress on plasma catecholamine levels before and after beta-adrenoceptor blocker treatment. Eur J Clin Pharmacol. 1992;43:11-15.
39. Freyschuss U, Hjemdahl P, Juhlin-Dannfelt A, et al. Cardiovascular and sympathoadrenal responses to mental stress: influence of beta-blockade. Am J Physiol. 1988;255:H1443-H1451.
40. Schror K. Aspirin and platelets: the antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxis. Semin Thromb Hemost. 1997;23:349-356.
41. Chen J, Lopez JA. Interactions of platelets with subendothelium and endothelium. Microcirculation. 2005;12:235-246.
42. Allen MT, Patterson SM. Hemoconcentration and stress: a review of physiological mechanisms and relevance for cardiovascular disease risk. Biol Psychol. 1995;41:1-27.
43. Lip GY, Lowe GD. Fibrin D-dimer: A useful marker for thrombogenesis? Clin Sci. 1995;89:205-214.
44. Chandler WL, Velan T. Plasmin generation and D-dimer formation during cardiopulmonary bypass. Blood Coagul Fibrinolysis. 2004;15:583-591.
45. Wirtz PH, Ehlert U, Emini L, et al. Anticipatory cognitive stress appraisal and the acute procoagulant stress response in men. Psychosom Med. 2006;68:851-858.
46. Larsson PT, Wallen NH, Hjemdahl P. Norepinephrine-induced human platelet activation in vivo is only partly counteracted by aspirin. Circulation. 1994;89:1951-1957.
47. Wallen NH, Held C, Rehnqvist N, et al. Effects of mental and physical stress on platelet function in patients with stable angina pectoris and healthy controls. Eur Heart J. 1997;18:807-815.
48. Mittleman MA, Maclure M, Sherwood JB, et al. Triggering of acute myocardial infarction onset by episodes of anger. Determinants of Myocardial Infarction Onset Study Investigators. Circulation. 1995;92:1720-1725.